InvestorsHub Logo
Followers 2
Posts 105
Boards Moderated 0
Alias Born 10/18/2019

Re: value1008 post# 671

Thursday, 01/02/2020 2:31:49 PM

Thursday, January 02, 2020 2:31:49 PM

Post# of 1121
just a comparison to Vascepa, they reduced TG by 7% with the 2 g dose in the MARINE trial (severe HTG). Pierre the COO and CSO mentioned in his last interview that the Capre 2 g reduced the TG by 15% in the severe strata in the Trifecta trial. so if we were able to achieve double reduction with the 2 g , even with a small sample of patients, I don't see why we cant do better in the 4 g
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ACST News